The DOI matches its Crossref record; 531 of the 531 references it cites were found in a registry or an index.
International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New Nomenclature
Open accessAbstract
is a prototypical GPCR for the development of peptide-based radiopharmaceuticals for diagnostic and therapeutic interventions. This review article summarizes findings published in the last 25 years on the physiology, pharmacology, and clinical applications related to SSTs. We also discuss potential future developments and propose a new nomenclature.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–400 of 531
Florio, T., Barbieri, F., Spaziante, R., Zona, G., Hofland, L. J., van Koetsveld, P. M., Feelders, R., Stalla, G. K., Theodoropoulou, M., Culler, M. D., et al. (2008) · Endocrine Related Cancer · doi:10.1677/erc-07-0271 · Cited by 110
Self-citationSchulz, S., Schreff, M., Schmidt, H. H. H. W., et al. (1998) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1998.00386.x · Cited by 109
Self-citationMolecular biology of somatostatin receptor subtypes
Patel, Y., Greenwood, M. T., Panetta, R., Hukovic, N., Grigorakis, S., Robertson, L.-A., & Srikant, C. B. (1996) · Metabolism · doi:10.1016/s0026-0495(96)90076-1 · Cited by 109
Ferrante, E., Pellegrini, C., Bondioni, S., et al. (2006) · Endocrine Related Cancer · doi:10.1677/erc.1.01191 · Cited by 109
Vaudry, H., Leprince, J., Chatenet, D., Fournier, A., Lambert, D. G., Mével, J. L., Ohlstein, E. H., Schwertani, A. G., Tostivint, H., & Vaudry, D. (2014) · Pharmacological Reviews · doi:10.1124/pr.114.009480 · Cited by 109
Somatostatin Depresses Excitatory but not Inhibitory Neurotransmission in Rat CA1 Hippocampus
Tallent, M. K., & Siggins, G. R. (1997) · Journal of Neurophysiology · doi:10.1152/jn.1997.78.6.3008 · Cited by 109
Day, R. W., Dong, W., Panetta, R., Kraicer, J., Greenwood, M. T., & Patel, Y. (1995) · Endocrinology · doi:10.1210/endo.136.11.7588263 · Cited by 108
Schottelius, M., Poethko, T., Herz, M., Reubi, J., Kessler, H., Schwaiger, M., & Wester, H. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0359 · Cited by 108
Self-citationTubby is required for trafficking G protein-coupled receptors to neuronal cilia
Sun, X., Haley, J., Bulgakov, O. V., Cai, X., McGinnis, J. F., & Li, T. (2012) · Cilia · doi:10.1186/2046-2530-1-21 · Cited by 108
Inhibitory Action of Natural Carrageenans on Herpes simplex Virus Infection of Mouse Astrocytes
Carlucci, M. J., Scolaro, L. A., & Damonte, E. B. (1999) · Chemotherapy · doi:10.1159/000007236 · Cited by 107
Function and expression of somatostatin receptors of the endocrine pancreas
Strowski, M. Z., & Blake, A. D. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.02.007 · Cited by 106
Chinezu, L., Vasiljevic, A., Jouanneau, E., François, P., Borda, A., Trouillas, J., & Raverot, G. (2014) · Human Pathology · doi:10.1016/j.humpath.2013.08.007 · Cited by 106
Scaffolding proteins at the postsynaptic density: shank as the architectural framework
Kreienkamp, H. J. (2008) · Handbook of experimental pharmacology · doi:10.1007/978-3-540-72843-6_15 · Cited by 105
Self-citationCloning, mRNA Expression, and Chromosomal Mapping of Mouse and Human Preprocortistatin
de Lecea, L., Ruiz‐Lozano, P., Danielson, P. E., Peelle-Kirley, J., Foye, P. E., Frankel, W. N., & Sutcliffe, J. G. (1997) · Genomics · doi:10.1006/geno.1997.4763 · Cited by 105
Tallent, M. K., Liapakis, G., O’Carroll, A., Lolait, S. J., Dichter, M. A., & Reisine, T. (1996) · Neuroscience · doi:10.1016/0306-4522(95)00510-2 · Cited by 104
Öberg, K., & Lamberts, S. W. J. (2016) · Endocrine Related Cancer · doi:10.1530/erc-16-0151 · Cited by 104
Distribution, Targeting, and Internalization of the sst4Somatostatin Receptor in Rat Brain
Schreff, M., Schulz, S., Händel, M., Keilhoff, G., Braun, H., Pereira, G., Klutzny, M., Schmidt, H., Wolf, G. L., & Höllt, V. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-10-03785.2000 · Cited by 103
Self-citationBito, H., Mori, M., Sakanaka, C., Takano, T., Honda, Z.-I., Gotoh, Y., Nishida, E., & Shimizu, T. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99936-9 · Cited by 103
Callaghan, B. P., & Furness, J. B. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.008433 · Cited by 102
Onoprishvili, I., Andria, M. L., Kramer, H. K., Ancevska-Taneva, N., Hiller, J. M., & Simon, E. J. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.5.1092 · Cited by 101
Ginj, M., Chen, J., Walter, M. A., Eltschinger, V., Reubi, J. C., & Maëcke, H. R. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.1136.11.3 · Cited by 101
SST3-selective potent peptidic somatostatin receptor antagonists
Reubi, J. C., Schaer, J., Wenger, S., Hoeger, C. A., Érchegyi, J., Waser, B., & Rivier, J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.250483897 · Cited by 100
sst2 somatostatin receptor expression reverses tumorigenicity of human pancreatic cancer cells.
Delesque, N., Buscail, L., Estève, J. P., Saint‐Laurent, N., Müller, C., Weckbecker, G., Bruns, C., Vaysse, N., & Susini, C. (1997) · PubMed · Cited by 99
Somatostatin: Analogs with Selected Biological Activities
Brown, M. R., Rivier, J., & Vale, W. (1977) · Science · doi:10.1126/science.867045 · Cited by 99
Cronin, M. J., Rogol, A. D., Myers, G. A., & Hewlett, E. L. (1983) · Endocrinology · doi:10.1210/endo-113-1-209 · Cited by 99
Mizutani, G., Nakanishi, Y., Watanabe, N., Honma, T., Obana, Y., Seki, T., Ohni, S., & Nemoto, N. (2012) · ACTA HISTOCHEMICA ET CYTOCHEMICA · doi:10.1267/ahc.12006 · Cited by 98
Helyes, Z., Pintér, E., Sándor, K., Elekes, K., Bánvölgyi, Á., Keszthelyi, D., Szőke, É., Tóth, D. M., Zoltán, S., Kereskai, L., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900681106 · Cited by 98
Cloning and expression of a rat somatostatin receptor enriched in brain.
Li, X. J., Forte, M. A., North, R. A., Ross, C. A., & Snyder, S. H. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)36609-8 · Cited by 95
Ayuk, J., Stewart, S. E., Stewart, P. M., & Sheppard, M. C. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2001-011913 · Cited by 95
Roth, A. J. K., Kreienkamp, H., Meyerhof, W., & Richter, D. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.38.23769 · Cited by 95
Self-citationFerjoux, G., Lopez, F., Estève, J., Ferrand, A., Vivier, É., Vely, F., Saint‐Laurent, N., Pradayrol, L., Buscail, L., & Susini, C. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.e03-02-0069 · Cited by 95
Bousquet, C., Guillermet‐Guibert, J., Saint‐Laurent, N., Archer-Lahlou, É., Lopez, F., Fanjul, M., Ferrand, A., Fourmy, D., Pichereaux, C., Monsarrat, B., et al. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601279 · Cited by 95
Self-citationReubi, J. C., Schaer, J., Markwalder, R. V., Waser, B., Horisberger, U., & Laissue, J. A. (1999) · PubMed · Cited by 95
The somatostatin receptor SSTR1 is coupled to phosphotyrosine phosphatase activity in CHO-K1 cells
Florio, T., Rim, C., Hershberger, R. E., Loda, M. F., & Stork, P. A. (1994) · Molecular Endocrinology · doi:10.1210/me.8.10.1289 · Cited by 94
Somatostatin receptor subtype 1 modulates basal inhibition of growth hormone release in somatotrophs
Kreienkamp, H., Akgün, E., Baumeister, H., Meyerhof, W., & Richter, D. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01582-3 · Cited by 94
Self-citationNicolas, G. P., Beykan, S., Bouterfa, H., Kaufmann, J., Bauman, A., Laßmann, M., Reubi, J. C., Rivier, J., Maëcke, H. R., Fani, M., et al. (2017) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.199737 · Cited by 94
Somatostatin Acts in CA1 and CA3 to Reduce Hippocampal Epileptiform Activity
Tallent, M. K., & Siggins, G. R. (1999) · Journal of Neurophysiology · doi:10.1152/jn.1999.81.4.1626 · Cited by 93
Pöll, F., Lehmann, D., Illing, S., Ginj, M., Jacobs, S., Lupp, A., Stumm, R. K., & Schulz, S. (2010) · Molecular Endocrinology · doi:10.1210/me.2009-0315 · Cited by 93
Self-citationReceptor Signaling and Endocytosis Are Differentially Regulated by Somatostatin Analogs
Liu, Q., Cescato, R., Dewi, D. A., Rivier, J., Reubi, J.-C., & Schönbrunn, A. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.011767 · Cited by 93
Somatostatin: An endogenous antiepileptic
Tallent, M. K., & Qiu, C. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2007.12.004 · Cited by 92
A new peptidic somatostatin agonist with high affinity to all five somatostatin receptors
Reubi, J. C., Eisenwiener, K., Rink, H., Waser, B., & Mäcke, H. R. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)02651-1 · Cited by 91
Modification of ghrelin receptor signaling by somatostatin receptor-5 regulates insulin release
Park, S., Jiang, H. F., Zhang, H., & Smith, R. G. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1209590109 · Cited by 91
Development of a selective agonist at the somatostatin receptor subtype sstr1.
Liapakis, G., Hoeger, C. A., Rivier, J., & Reisine, T. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12384-7 · Cited by 88
Moneta, D., Richichi, C., Aliprandi, M., Dournaud, P., Dutar, P., Billard, J., Carlo, A.-S., Viollet, C., Hannon, J. P., Fehlmann, D., et al. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.02146.x · Cited by 88
Self-citationDalm, V. A. S. H., van Hagen, P. M., van Koetsveld, P. M., Langerak, A. W., van der Lely, A. J., Lamberts, S. W. J., & Hofland, L. J. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020950 · Cited by 88
The effects of somatostatin analogue therapy on pituitary tumor volume in patients with acromegaly
Colao, A., Auriemma, R., & Pivonello, R. (2015) · Pituitary · doi:10.1007/s11102-015-0677-y · Cited by 87
Zatelli, M. C., Tagliati, F., Taylor, J. E., Rossi, R., Culler, M. D., & Uberti, E. C. D. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.5.7489 · Cited by 87
Self-citationHighly Potent Cyclic Disulfide Antagonists of Somatostatin
Hocart, S. J., Jain, R., Murphy, W. A., Taylor, J. E., & Coy, D. H. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm9806289 · Cited by 87
Fehlmann, D., Langenegger, D., Schuepbach, E., Siehler, S., Feuerbach, D., & Hoyer, D. (2000) · Journal of Physiology-Paris · doi:10.1016/s0928-4257(00)00208-4 · Cited by 86
Beaudet, A., Greenspun, D., Raelson, J., & Tannenbaum, G. S. (1995) · Neuroscience · doi:10.1016/0306-4522(94)00486-o · Cited by 86
Use of molecular targeted agents for the diagnosis, staging and therapy of neuroendocrine malignancy
Hicks, R. J. (2010) · Cancer Imaging · doi:10.1102/1470-7330.2010.9007 · Cited by 86
Srirajaskanthan, R., Watkins, J., Marelli, L., Khan, K., & Caplin, M. E. (2009) · Neuroendocrinology · doi:10.1159/000179899 · Cited by 85
Kreienkamp, H., Hönck, H., & Richter, D. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01437-3 · Cited by 85
Self-citationAfargan, M., Janson, E. T., Gelerman, G., Rosenfeld, R., Ziv, O., Karpov, O., Wolf, A., Bracha, M., Shohat, D., Liapakis, G., et al. (2001) · Endocrinology · doi:10.1210/en.142.1.477 · Cited by 85
Ren, S.-G., Taylor, J., Dong, J. Z., Yu, R., Culler, M. D., & Melmed, S. K. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030303 · Cited by 84
Self-citationEndothelin-converting enzyme 1 degrades neuropeptides in endosomes to control receptor recycling
Roosterman, D., Cottrell, G. S., Padilla, B. E., Muller, L., Eckman, C. B., Bunnett, N. W., & Steinhoff, M. S. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701910104 · Cited by 84
González‐Rey, E., Chorny, A., del Moral, R. G., Varela, N., & Delgado, M. (2006) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2006.062703 · Cited by 83
Meisetschläger, G., Poethko, T., Stahl, A. R., Wolf, I., Scheidhauer, K., Schottelius, M., Herz, M., Wester, H. J., & Schwaiger, M. (2006) · PubMed · Cited by 83
Self-citationToumpanakis, C., & Caplin, M. E. (2013) · Seminars in Oncology · doi:10.1053/j.seminoncol.2012.11.006 · Cited by 82
Expression of the Five Different Somatostatin Receptor Subtypes in Endocrine Cells of the Pancreas
Portela‐Gomes, G. M., Stridsberg, M., Grimelius, L., Öberg, K., & Janson, E. T. (2000) · Applied immunohistochemistry & molecular morphology · doi:10.1097/00129039-200006000-00007 · Cited by 82
Somatostatin Increases a Voltage-Insensitive K+Conductance in Rat CA1 Hippocampal Neurons
Schweitzer, P., Madamba, S. G., & Siggins, G. R. (1998) · Journal of Neurophysiology · doi:10.1152/jn.1998.79.3.1230 · Cited by 82
Hyperglycemia induced by pasireotide in patients with Cushing’s disease or acromegaly
Silverstein, J. M. (2016) · Pituitary · doi:10.1007/s11102-016-0734-1 · Cited by 81
Cell Specific Expression of the SST2A and SST5 Somatostatin Receptors in the Rat Anterior Pituitary
Mezey, É., Hunyady, B., Mitra, S. W., Hayes, E., Liu, Q., Schaeffer, J. M., & Schönbrunn, A. (1998) · Endocrinology · doi:10.1210/endo.139.1.5807 · Cited by 80
Helboe, L., Stidsen, C. E., & Møller, M. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-13-04938.1998 · Cited by 80
Anxiolytic and antidepressant actions of somatostatin: the role of sst2 and sst3 receptors
Engin, E., & Treit, D. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1605-5 · Cited by 79
The evolution of somatostatin in vertebrates
Liu, Y., Lu, D., Zhang, Y., Li, S., Liu, X., & Lin, H. (2010) · Gene · doi:10.1016/j.gene.2010.04.016 · Cited by 79
Somatostatin Receptor Subtype 4 Couples to the M-Current to Regulate Seizures
Qiu, C., Zeyda, T., Johnson, B. N., Hochgeschwender, U., de Lecea, L., & Tallent, M. K. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.4679-07.2008 · Cited by 79
The Somatostatin Receptor in Human Pancreatic β-Cells
Braun, M. (2014) · Vitamins and hormones · doi:10.1016/b978-0-12-800174-5.00007-7 · Cited by 79
Elston, M. S., Meyer-Rochow, G. Y., Conaglen, H. M., Clarkson, A., Clifton-Bligh, R. J., Conaglen, J. V., & Gill, A. J. (2014) · Human Pathology · doi:10.1016/j.humpath.2014.11.012 · Cited by 78
X. International Union of Pharmacology recommendations for nomenclature of new receptor subtypes.
Vanhoutte, P. M., Humphrey, P. P. A., & Spedding, M. (1996) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06936-4 · Cited by 78
Dolais-Kitabgi, J., Kitabgi, P., Brazeau, P., & Freychet, P. (1979) · Endocrinology · doi:10.1210/endo-105-1-256 · Cited by 77
Allen, J. P., Hathway, G. J., Clarke, N. J., Jowett, M. I., Topps, S., Kendrick, K. M., Humphrey, P. P. A., Wilkinson, L. S., & Emson, P. C. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02629.x · Cited by 76
Tateno, T., Masako, K. A. T. O., Tani, Y., Oyama, K., Yamada, S., & Hirata, Y. (2009) · Endocrine Journal · doi:10.1507/endocrj.k08e-186 · Cited by 76
Somatostatin system: molecular mechanisms regulating anterior pituitary hormones
Eigler, T., & Ben-Shlomo, A. (2014) · Journal of Molecular Endocrinology · doi:10.1530/jme-14-0034 · Cited by 76
Cervia, D., & Bagnoli, P. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.06.010 · Cited by 75
Expression of five somatostatin receptor mRNAs in the human brain and pituitary
Thoss, V. S., P�rez, J., Probst, A., & Hoyer, D. (1996) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00168430 · Cited by 75
Ferone, D., van Hagen, M. P., Kwekkeboom, D. J., van Koetsveld, P. M., Mooy, D. M., Lichtenauer‐Kaligis, E., Schönbrunn, A., Colao, A., Lamberts, S. W. J., & Hofland, L. J. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.4.6547 · Cited by 75
Mayr, B. M., Buslei, R., Theodoropoulou, M., Stalla, G. K., Buchfelder, M., & Schöfl, C. (2013) · European Journal of Endocrinology · doi:10.1530/eje-13-0134 · Cited by 75
Roth, A. J. K., Kreienkamp, H., Nehring, R. B., Roosterman, D., Meyerhof, W., & Richter, D. (1997) · DNA and Cell Biology · doi:10.1089/dna.1997.16.111 · Cited by 74
Self-citationDurán‐Prado, M., Malagón, M. M., Gracia‐Navarro, F., & Castano, J. P. (2007) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2007.12.006 · Cited by 74
Srikant, C. B., & Shen, S. H. (1996) · Endocrinology · doi:10.1210/en.137.8.3461 · Cited by 73
Wente, W., Stroh, T., Beaudet, A., Richter, D., & Kreienkamp, H. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507198200 · Cited by 73
Self-citationXu, Y., Berelowitz, M., & Bruno, J. F. (1995) · Endocrinology · doi:10.1210/endo.136.11.7588243 · Cited by 73
Gahete, M. D., Rubio, A., Durán‐Prado, M., Ávila, J., Luque, R. M., & Castano, J. P. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1385 · Cited by 72
Subtype-specific signaling mechanisms of somatostatin receptors SSTR1 and SSTR2.
Hou, C., Gilbert, R., & Barber, D. L. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34068-1 · Cited by 72
Ben-Shlomo, A., SCHMID, H. A., Wawrowsky, K., Pichurin, O., Hubina, E., Chesnokova, V., Liu, N., Culler, M. D., & Melmed, S. K. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1311 · Cited by 72
Self-citationRoles of Hippocampal Somatostatin Receptor Subtypes in Stress Response and Emotionality
Prévot, T. D., Gastambide, F., Viollet, C., Henkous, N., Martel, G., Epelbaum, J., Béracochéa, D., & Guillou, J. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.281 · Cited by 72
Zitzer, H., Richter, D., & Kreienkamp, H. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.26.18153 · Cited by 71
Self-citationNovel insights in somatostatin receptor physiology
Tulipano, G., & Schulz, S. (2007) · European Journal of Endocrinology · doi:10.1530/eje.1.02354 · Cited by 71
Self-citationPscherer, A., Dörflinger, U., Kirfel, J., Gawlas, K., Rüschoff, J., Buettner, R., & Schüle, R. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb01058.x · Cited by 71
Okuwaki, K., Kida, M., Mikami, T., Yamauchi, H., Imaizumi, H., Miyazawa, S., Iwai, T., Takezawa, M., Saegusa, M., Watanabe, M., et al. (2013) · Cancer · doi:10.1002/cncr.28341 · Cited by 70
Hervieu, G. J., & Emson, P. C. (1998) · Neuroscience · doi:10.1016/s0306-4522(98)00024-4 · Cited by 70
SSTR3 is a putative target for the medical treatment of gonadotroph adenomas of the pituitary
Lee, M., Lupp, A., Mendoza, N., Martin, N. M., Beschorner, R., Honegger, J. B., Schlegel, J., Shively, T., Pulz, E., Schulz, S., et al. (2014) · Endocrine Related Cancer · doi:10.1530/erc-14-0472 · Cited by 70
Self-citationSDZ CO 611: a highly potent glycated analog of somatostatin with improved oral activity
Albert, R., Marbach, P., Bauer, W., Briner, U., Fricker, G., Brums, C., & Pless, J. (1993) · Life Sciences · doi:10.1016/0024-3205(93)90703-6 · Cited by 70
Gu, F., Schumacher, F. R., Canzian, F., Allen, N. E., Albanes, D., Berg, C. D., Berndt, S. I., Boeing, H., Bueno-de-Mesquita, H. B., Buring, J. E., et al. (2010) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-10-0507 · Cited by 70
Zambre, Y., Ling, Z., Chen, M.-C., Hou, X., Woon, C.-W., Culler, M. D., Taylor, J. E., Coy, D. H., Schravendijk, C. V., Schuit, F. C., et al. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00010-6 · Cited by 69
Self-citationCortistatin—Functions in the central nervous system
de Lecea, L. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2007.12.014 · Cited by 69
Duerson, K. C., White, R. E., JIANG, F., Schönbrunn, A., & Armstrong, D. L. (1996) · Neuropharmacology · doi:10.1016/0028-3908(96)00131-1 · Cited by 69
Quantitative and functional expression of somatostatin receptor subtypes in human thymocytes
Ferone, D., Pivonello, R., van Hagen, P. M., Dalm, V. A. S. H., Lichtenauer-Kaligis, E. G. R., Waaijers, M., van Koetsveld, P. M., Mooy, D. M., Colao, A., Minuto, F. M., et al. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00205.2001 · Cited by 69
Tannenbaum, G. S., Zhang, W., Lapointe, M., Zeitler, P. S., & Beaudet, A. (1998) · Endocrinology · doi:10.1210/endo.139.3.5977 · Cited by 68
Ginj, M., Zhang, H., Eisenwiener, K., Wild, D., Schulz, S., Rink, H., Cescato, R., Reubi, J. C., & Maëcke, H. R. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1687 · Cited by 68
Self-citationZatelli, M. C. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.5.2161 · Cited by 68
Green, J. A., Schmid, C. L., Bley, E., Monsma, P. C., Brown, A., Bohn, L. M., & Mykytyn, K. (2016) · Molecular and Cellular Biology · doi:10.1128/mcb.00765-15 · Cited by 67
MOLECULAR EVOLUTION OF GPCRS: Somatostatin/urotensin II receptors
Tostivint, H., Daza, D. O., Bergqvist, C. A., Quan, F. B., Bougerol, M., Lihrmann, I., & Larhammar, D. (2014) · Journal of Molecular Endocrinology · doi:10.1530/jme-13-0274 · Cited by 66
Scheich, B., Gaszner, B., Kormos, V., László, K., Ádori, C., Borbély, É., Hajna, Z., Tékus, V., Bölcskei, K., Ábrahám, I. M., et al. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.09.021 · Cited by 65
Schottelius, M., Šimeček, J., Hoffmann, F., Willibald, M., Schwaiger, M., & Wester, H. (2015) · EJNMMI Research · doi:10.1186/s13550-015-0099-x · Cited by 64
Self-citationTorrisani, J., Hanoun, N., Laurell, H., Lopez, F., Maoret, J.-J., Souque, A., Susini, C., Cordelier, P., & Buscail, L. (2008) · Endocrinology · doi:10.1210/en.2007-1525 · Cited by 63
Casini, G., Catalani, E., Monte, M. D., & Bagnoli, P. (2005) · PubMed · doi:10.14670/hh-20.615 · Cited by 60
Ben-Shlomo, A., Wawrowsky, K., Proekt, I., Wolkenfeld, N. M., Ren, S.-G., Taylor, J., Culler, M. D., & Melmed, S. K. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501998200 · Cited by 60
Self-citationSchindler, M., Humphrey, P. P. A., Löhrke, S., & Friauf, E. (1999) · Neuroscience · doi:10.1016/s0306-4522(98)00483-7 · Cited by 60
Bär, K., Schurigt, U., Scholze, A., et al. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.04.051 · Cited by 60
Identification of Prognostic Biomarkers for Prostate Cancer
Kosari, F., Munz, J. M. A., Savci-Heijink, C. D., Spiro, C., Klee, E. W., Kube, D. M., Tillmans, L. S., Slezak, J. M., Karnes, R. J., Cheville, J. C., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1494 · Cited by 60
Kong, G., Callahan, J., Hofman, M. S., Pattison, D. A., Akhurst, T. J., Michael, M., Eu, P., & Hicks, R. J. (2016) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-016-3527-x · Cited by 60
On the Role of Somatostatin in Seizure Control: Clues from the Hippocampus
Binaschi, A., Bregola, G., & Simonato, M. (2003) · Reviews in the Neurosciences · doi:10.1515/revneuro.2003.14.3.285 · Cited by 59
Momiyama, T., & Záborszky, L. (2006) · Journal of Neurophysiology · doi:10.1152/jn.00507.2005 · Cited by 59
Kreuzer, O. J., Krisch, B., Déry, O., Bunnett, N. W., & Meyerhof, W. (2001) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.2001.00630.x · Cited by 58
Corleto, V. D., Falconi, M., Panzuto, F., Milione, M., Luca, O. D., Perri, P., Cannizzaro, R., Bordi, C., Pederzoli, P., Scarpa, A., et al. (2008) · Neuroendocrinology · doi:10.1159/000167796 · Cited by 58
Videau, C., Hochgeschwender, U., Kreienkamp, H., Brennan, M. B., Viollet, C., Richter, D., & Epelbaum, J. (2003) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-003-0758-8 · Cited by 58
Self-citationStumm, R. K., Zhou, C., Schulz, S., Endres, M., Kronenberg, G., Allen, J. P., Tulipano, G., & Höllt, V. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.3834-04.2004 · Cited by 58
Self-citationStroh, T., Jackson, A. C., Sarret, P., Farra, C. D., Vincent, J., Kreienkamp, H., Mazella, J., & Beaudet, A. (2000) · Endocrinology · doi:10.1210/endo.141.1.7259 · Cited by 58
Self-citationSomatostatin analogues increase AIP expression in somatotropinomas, irrespective of Gsp mutations
Jaffrain‐Rea, M., Rotondi, S., Turchi, A., Occhi, G., Barlier, A., Peverelli, E., Rostomyan, L., Defilles, C., Angelini, M., Oliva, M. A., et al. (2013) · Endocrine Related Cancer · doi:10.1530/erc-12-0322 · Cited by 58
Raynor, K., Lucki, I., & Reisine, T. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)38097-3 · Cited by 58
Gatto, F., Barbieri, F., Gatti, M., Würth, R., Schulz, S., Ravetti, J., Zona, G., Culler, M. D., Saveanu, A., Giusti, M., et al. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04200.x · Cited by 57
Self-citationBassant, M., Simon, A., Poindessous‐Jazat, F., Csaba, Z., Epelbaum, J., & Dournaud, P. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.4619-04.2005 · Cited by 57
Self-citationZatelli, M. C., Tagliati, F., Piccin, D., Taylor, J. E., Culler, M. D., Bondanelli, M., & Uberti, E. C. D. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02307-0 · Cited by 57
Self-citationIwanaga, T., Miki, T., & Takahashi‐Iwanaga, H. (2011) · Biomedical Research · doi:10.2220/biomedres.32.73 · Cited by 57
Developmental changes in frequency of the ciliary somatostatin receptor 3 protein
Stanić, D., Malmgren, H., He, H., Scott, L., Aperia, A. C., & Hökfelt, T. G. M. (2008) · Brain Research · doi:10.1016/j.brainres.2008.10.024 · Cited by 56
Hannon, J. P., Petrucci, C., Fehlmann, D., Viollet, C., Epelbaum, J., & Hoyer, D. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(01)00186-1 · Cited by 56
Elekes, K., Helyes, Z., Kereskai, L., Sándor, K., Pintér, E., Pozsgai, G., Tékus, V., Bánvölgyi, Á., Németh, J., Szúts, T., et al. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.09.033 · Cited by 55
Lanneau, C., Bluet‐Pajot, M., Zizzari, P., Csaba, Z., Dournaud, P., Helboe, L., Hoyer, D., Pellegrini, E., Tannenbaum, G. S., Epelbaum, J., et al. (2000) · Endocrinology · doi:10.1210/endo.141.3.7349 · Cited by 55
Self-citationSomatostatin analogs which inhibit glucagon and growth hormone more than insulin release
Meyers, C. A., Arimura, A., Gordin, A., Fernández-Durango, R., Coy, D. H., Schally, A. V., Drouin, J., Ferland, L., Beaulieu, M. J., & Labrie, F. (1977) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(77)90349-7 · Cited by 54
Yang, L., Guo, L., Pasternak, A., Mosley, R., Rohrer, S. P., Birzin, E. T., Foor, F., Cheng, K., Schaeffer, J. M., & Patchett, A. A. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm980194h · Cited by 54
Chalabi‐Dchar, M., Cassant‐Sourdy, S., Duluc, C., Fanjul, M., Lulka, H., Samain, R., Roche, C., Breibach, F., Delisle, M., Poupot, M., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.02.009 · Cited by 54
Self-citationSomatostatin Depresses Long-Term Potentiation and Ca2+ Signaling in Mouse Dentate Gyrus
Baratta, M. V., Lamp, T., & Tallent, M. K. (2002) · Journal of Neurophysiology · doi:10.1152/jn.00398.2002 · Cited by 54
Liu, S., Tang, C., Ho, B., Ankersen, M., Stidsen, C. E., & Crider, A. M. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm980118e · Cited by 54
The somatostatin sst1 receptor: an autoreceptor for somatostatin in brain and retina?
Thermos, K., Bagnoli, P., Epelbaum, J., & Hoyer, D. (2005) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.09.003 · Cited by 53
Sellers, L. A., Feniuk, W., Humphrey, P. P. A., & Lauder, H. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.23.16423 · Cited by 53
Matei, D. V., Renne, G., Pimentel, M., Sandri, M. T., Zorzino, L., Botteri, E., Cicco, C. D., Musi, G., Brescia, A., Mazzoleni, F., et al. (2012) · Clinical Genitourinary Cancer · doi:10.1016/j.clgc.2011.12.004 · Cited by 53
Portela‐Gomes, G. M., Stridsberg, M., Grimelius, L., Rorstad, O. P., & Janson, E. T. (2007) · Endocrine Pathology · doi:10.1007/s12022-007-0014-8 · Cited by 53
Somatostatin activates two types of inwardly rectifying K+ channels in MIN‐6 cells
Smith, P. A., Sellers, L. A., & Humphrey, P. P. A. (2001) · The Journal of Physiology · doi:10.1111/j.1469-7793.2001.0127g.x · Cited by 53
Truncated somatostatin receptors as new players in somatostatin–cortistatin pathophysiology
Córdoba‐Chacón, J., Gahete, M. D., Durán‐Prado, M., Luque, R. M., & Castano, J. P. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.05985.x · Cited by 52
Imhof, A., Glück, L., Gajda, M., Lupp, A., Bräuer, R., Schaible, H., & Schulz, S. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30410 · Cited by 52
Self-citationShi, T.-J. S., Xiang, Q., Zhang, M.-D., Barde, S. S., Kai-Larsen, Y., Fried, K., Josephson, A., Glück, L., Deyev, S. M., Zvyagin, A. V., et al. (2014) · Molecular Pain · doi:10.1186/1744-8069-10-12 · Cited by 52
Self-citationSaveanu, A., Muresan, M., Micco, C. D., Taïeb, D., Germanetti, A. L., Sebag, F., Henry, J.-F., Brunaud, L., Enjalbert, A., Weryha, G., et al. (2011) · Endocrine Related Cancer · doi:10.1530/erc-10-0175 · Cited by 52
Scheich, B., Csekő, K., Borbély, É., Ábrahám, I. M., CSERNUS, V. J., Gaszner, B., & Helyes, Z. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.01.039 · Cited by 52
The oncogenic role of the spliced somatostatin receptor sst5TMD4 variant in prostate cancer
Hormaechea‐Agulla, D., Jiménez‐Vacas, J. M., Gómez‐Gómez, E., L‐López, F., Carrasco‐Valiente, J., Valero-Rosa, J., Moreno, M. M., Sánchez‐Sánchez, R., Ortega-Salas, R. M., Gracia‐Navarro, F., et al. (2017) · The FASEB Journal · doi:10.1096/fj.201601264rrr · Cited by 52
Self-citationvan der Pas, R., Feelders, R. A., Gatto, F., de Bruin, C., Pereira, A. M., van Koetsveld, P. M., Sprij-Mooij, D. M., Waaijers, A. M., Dogan, F., Schulz, S., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-1987 · Cited by 51
Self-citationNogueira, V. D. S. N., Correa, J. M. S., Puga, M. E. D. S., Silva, E. M. K., & Boguszewski, C. L. (2014) · Pituitary · doi:10.1007/s11102-014-0602-9 · Cited by 50
Buchan, A. M. J., Lin, C., Choi, J. C. S., & Barber, D. L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201261200 · Cited by 50
Gardair, C., Samimi, M., Touzé, A., Coursaget, P., Lorette, G., Caille, A., Wierzbicka, E., Croué, A., Avenel-Audran, M., Aubin, F., et al. (2015) · Neuroendocrinology · doi:10.1159/000381062 · Cited by 50
Sándor, K., Elekes, K., Szabó, Á., Pintér, E., Engström, M., Wurster, S., Szolcsányi, J., & Helyes, Z. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.03.082 · Cited by 50
Zeng, M., Shang, Y., Guo, T., He, Q., Yung, W., Liu, K., & Zhang, M. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1523265113 · Cited by 50
Pittaluga, A., Feligioni, M., Longordo, F., Arvigo, M., & Raiteri, M. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.079590 · Cited by 49
Laval, S., Laklai, H., Fanjul, M., Pucelle, M., Laurell, H., Billon-Galés, A., Guellec, S. L., Delisle, M., Sonnenberg, A., Susini, C., et al. (2013) · Oncogene · doi:10.1038/onc.2013.146 · Cited by 49
Self-citationAlderton, F., Humphrey, P. P. A., & Sellers, L. A. (2001) · Molecular Pharmacology · doi:10.1124/mol.59.5.1119 · Cited by 48
Córdoba‐Chacón, J., Gahete, M. D., Culler, M. D., Castano, J. P., Kineman, R. D., & Luque, R. M. (2011) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2011.02261.x · Cited by 48
Self-citationBrain–gut communication: cortistatin, somatostatin and ghrelin
Broglio, F., Papotti, M. G., Muccioli, G., & Ghigo, E. (2007) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2007.06.004 · Cited by 48
Allìa, E., Tarabra, E., Volante, M., Cerrato, M., Ghigo, E., Muccioli, G., & Papotti, M. G. (2005) · The Journal of Pathology · doi:10.1002/path.1839 · Cited by 48
Kim, S., Kim, J. W., Han, S., Oh, D., Lee, S., Kim, D., Im, S., Kim, T., Heo, D. S., & Bang, Y. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-448 · Cited by 48
Moatassim-Billah, S., Duluc, C., Samain, R., Jean, C., Perraud, A., Decaup, E., Cassant‐Sourdy, S., Bakri, Y., Sèlves, J., SCHMID, H. A., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9296 · Cited by 48
Self-citationSiehler, S., & Hoyer, D. (1999) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s002109900144 · Cited by 46
Csaba, Z., Lelouvier, B., Viollet, C., Ghouzzi, V. E., Toyama, K., Videau, C., Bernard, V., & Dournaud, P. (2007) · Traffic · doi:10.1111/j.1600-0854.2007.00580.x · Cited by 46
Self-citationBurke, P. G. R., Li, Q., Costin, M. L., McMullan, S., Pilowsky, P. M., & Goodchild, A. K. (2008) · Hypertension · doi:10.1161/hypertensionaha.108.118224 · Cited by 46
Lepousez, G., Mouret, A., Loudes, C., Epelbaum, J., & Viollet, C. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.4958-09.2010 · Cited by 46
Sampedro-Nuñez, M. A., Luque, R. M., Ramos-Levi, A. M., Gahete, M. D., Serrano-Somavilla, A., Villa-Osaba, A., Adrados, M., Ibáñez‐Costa, A., Martín‐Pérez, E., Culler, M. D., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6565 · Cited by 46
Self-citationMonte, M. D., Petrucci, C., Vasilaki, A., Cervia, D., Grouselle, D., Epelbaum, J., Kreienkamp, H., Richter, D., Hoyer, D., & Bagnoli, P. (2003) · Neuropharmacology · doi:10.1016/s0028-3908(03)00296-x · Cited by 45
Self-citationDesign, Synthesis, and Biological Evaluation of Somatostatin-Based Radiopeptides
Ginj, M., Schmitt, J. S., Chen, J., Waser, B., Reubi, J., de Jong, M., Schulz, S., & Maëcke, H. R. (2006) · Chemistry & Biology · doi:10.1016/j.chembiol.2006.08.012 · Cited by 45
Self-citationAlbert, R., Smith-Jones, P. M., Stolz, B., et al. (1998) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(98)00187-5 · Cited by 45
Laklai, H., Laval, S., Dumartin, L., Rochaix, P., Hagedorn, M., Bikfalvi, A., Guellec, S. L., Delisle, M., Schally, A. V., Susini, C., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908674106 · Cited by 45
Self-citationDörflinger, U., Pscherer, A., Moser, M., et al. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.5.3736 · Cited by 45
Somatostatin receptor 2A in gliomas: Association with oligodendrogliomas and favourable outcome
Kiviniemi, A., Gardberg, M., Kivinen, K., Posti, J. P., Vuorinen, V., Sipilä, J., Rahi, M., Sankinen, M., & Minn, H. R. I. (2017) · Oncotarget · doi:10.18632/oncotarget.17097 · Cited by 45
Differential regulation of somatostatin receptor types 1–5 in rat aorta after angioplasty
Khare, S., Kumar, U., Sasi, R., Puebla, L., Calderon, L., Lemström, K., Häyry, P., & Patel, Y. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.2.387 · Cited by 44
Vlotides, G., Cruz-Soto, M. E., Rubinek, T., Eigler, T., Auernhammer, C. J., & Melmed, S. K. (2006) · Molecular Endocrinology · doi:10.1210/me.2006-0280 · Cited by 44
Self-citationStructural and compositional determinants of cortistatin activity
Criado, J. R., Li, H., Jiang, X., Spina, M. G., Huitrón‐Reséndiz, S., Liapakis, G., Calbet, M., Siehler, S., Henriksen, S. J., Koob, G. K., et al. (1999) · Journal of Neuroscience Research · Cited by 44
Evidence for Somatostatin receptor 2 in thyroid tissue
Druckenthaner, M., Schwarzer, C., Ensinger, C., Gabriel, M., Prommegger, R., Riccabona, G., & Decristoforo, C. (2006) · Regulatory Peptides · doi:10.1016/j.regpep.2006.08.005 · Cited by 44
Pituitary Medicine From Discovery to Patient-Focused Outcomes
Melmed, S. K. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-3653 · Cited by 44
Self-citationZhang, Beaudet, & Tannenbaum (1999) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.1999.00295.x · Cited by 43
Daza, D. O., Sundström, G., Bergqvist, C. A., & Larhammar, D. (2012) · BMC Evolutionary Biology · doi:10.1186/1471-2148-12-231 · Cited by 43
Stollberg, S., Kämmerer, D., Neubauer, E., Schulz, S., Simonitsch‐Klupp, I., Kiesewetter, B., Raderer, M., & Lupp, A. (2016) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-016-2220-6 · Cited by 43
Self-citationThe role of brain somatostatin receptor 2 in the regulation of feeding and drinking behavior
Stengel, A., Karasawa, H., & Taché, Y. (2015) · Hormones and Behavior · doi:10.1016/j.yhbeh.2015.05.009 · Cited by 42
Qiu, C. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i13.2011 · Cited by 41
Jiang, N., Furue, H., Katafuchi, T., & Yoshimura, M. (2003) · Neuroscience Research · doi:10.1016/s0168-0102(03)00183-4 · Cited by 41
WILKINSON, G. F., Feniuk, W., & Humphrey, P. P. A. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701116 · Cited by 41
Tirone, T. A., Norman, M. A., Moldovan, S., DeMayo, F. J., Wang, X. P., & Brunicardi, F. C. (2003) · Pancreas · doi:10.1097/00006676-200304000-00025 · Cited by 41
Basivireddy, J., Somvanshi, R. K., Romero, I. A., Weksler, B. B., Couraud, P., Oger, J., & Kumar, U. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.06.001 · Cited by 41
Superagonism at the Human Somatostatin Receptor Subtype 4
Engström, M., Tomperi, J., El-Darwish, K., Åhman, M. J., Savola, J., & Wurster, S. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.075531 · Cited by 41
Souza‐Moreira, L., Morell, M. H., Delgado‐Maroto, V., Pedreño, M., Martinez-Escudero, L., Caro, M., O’Valle, F., Luque, R. M., Gallo, M., de Lecea, L., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300384 · Cited by 41
Takei, M., Suzuki, M., Kajiya, H., Ishii, Y., Tahara, S., Miyakoshi, T., Egashira, N., Takekoshi, S., Sanno, N., Teramoto, A., et al. (2007) · Endocrine Pathology · doi:10.1007/s12022-007-9004-0 · Cited by 41
Dynamics of Somatostatin Type 2A Receptor Cargoes in Living Hippocampal Neurons
Lelouvier, B., Tamagno, G., Kaindl, A. M., Roland, A. B., Lelièvre, V., Verche, V. L., Loudes, C., Gressèns, P., Faivre‐Bauman, A., Lenkei, Z., et al. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.4379-07.2008 · Cited by 40
Self-citationAgonist-biased Trafficking of Somatostatin Receptor 2A in Enteric Neurons
Zhao, P., Canals, M., Murphy, J. E., Klingler, D., Eriksson, E. M., Pelayo, J., Hardt, M., Bunnett, N. W., & Poole, D. P. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.496414 · Cited by 40
Medina, D. L., Velasco, J. A., & Santisteban, P. (1999) · Endocrinology · doi:10.1210/endo.140.1.6426 · Cited by 40
Mawrin, C., Schulz, S., Pauli, S. U., Treuheit, T., Diete, S., Dietzmann, K., Firsching, R. P., Schulz, S., & Höllt, V. (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.1.13 · Cited by 40
Self-citationSomatostatin and diabetic retinopathy: current concepts and new therapeutic perspectives
Hernández, C., Simó‐Servat, O., & Simó, R. (2014) · Endocrine · doi:10.1007/s12020-014-0232-z · Cited by 39
Fani, M., Mueller, A., Tamma, M., Nicolas, G., Rink, H. R., Cescato, R., Reubi, J. C., & Maëcke, H. R. (2010) · Journal of Nuclear Medicine · doi:10.2967/jnumed.110.076695 · Cited by 39
Guadiana, S. M., Parker, A. K., Filho, G. F., Sequeira, A. R., Semple‐Rowland, S. L., Shaw, G., Mandel, R. J., Foster, T. C., Kumar, A., & Sarkisian, M. R. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00127 · Cited by 39
Protective effects of cortistatin (CST-14) against kainate-induced neurotoxicity in rat brain
Braun, H., Schulz, S., Becker, A., Schröder, H., & Höllt, V. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00609-x · Cited by 38
Self-citationCloning, expression and pharmacological characterisation of the mouse somatostatin sst5 receptor
Feuerbach, D., Fehlmann, D., Nunn, C., Siehler, S., Langenegger, D., Bouhelal, R., Seuwen, K., & Hoyer, D. (2000) · Neuropharmacology · doi:10.1016/s0028-3908(00)00063-0 · Cited by 38
Pöll, F., Doll, C., & Schulz, S. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.224899 · Cited by 38
Self-citationBarnes, K., Walkden, B. J., Wilkinson, T. C., & Turner, A. J. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68020570.x · Cited by 38
Somatostatin regulates tight junction function and composition in human keratinocytes
Vockel, M., Breitenbach, U., Kreienkamp, H., & Brandner, J. M. (2010) · Experimental Dermatology · doi:10.1111/j.1600-0625.2010.01101.x · Cited by 37
Self-citation
Cited by
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors
Alexander, S. P. H., Christopoulos, A., Davenport, A. P., Kelly, E., Mathie, A. A., Peters, J. A., Veale, E. L., Armstrong, J. F., Faccenda, E., Harding, S. D., et al. (2023) · British Journal of Pharmacology · doi:10.1111/bph.16177 · Cited by 392
Self-citationClinical Biology of the Pituitary Adenoma
Melmed, S., Kaiser, U. B., Lopes, M. B., Bertherat, J., Syro, L. V., Raverot, G., Reincke, M., Johannsson, G., Beckers, A., Fleseriu, M., et al. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnac010 · Cited by 321
Self-citationSomatostatin Analogs in Clinical Practice: A Review
Gomes-Porras, M., Cárdenas-Salas, J., & Álvarez-Escolá, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051682 · Cited by 264
Klomp, M. J., Dalm, S. U., de Jong, M., Feelders, R. A., Hofland, J., & Hofland, L. J. (2021) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-020-09607-z · Cited by 69
Radiolabeled somatostatin analogs-a continuously evolving class of radiopharmaceuticals.
Fani, M., Mansi, R., Nicolas, G. P., & Wild, D. (2022) · Cancers · doi:10.3390/cancers14051172 · Cited by 56
Metadata
- Authors
- Günther, T., Tulipano, G., Dournaud, P., Bousquet, C., Csaba, Z., Kreienkamp, H.-J., Lupp, A., Korbonits, M., Castaño, J. P., Wester, H.-J., Culler, M., Melmed, S., & Schulz, S.
- Venue
- Pharmacological Reviews
- Publisher
- Elsevier BV
- Published
- 2018-10
- Volume
- 70
- Issue
- 4
- Pages
- 763-835
- ISSN
- 0031-6997 (ISSN-L)
- OpenAlex
- W2889994902
- Cited by
- 253
- References
- 531
- FWCI
- 9.59
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.